FATAL HEMOPTYSIS IN PULMONARY FILAMENTOUS MYCOSIS - AN UNDEREVALUATEDCAUSE OF DEATH IN PATIENTS WITH ACUTE-LEUKEMIA IN HEMATOLOGICAL COMPLETE REMISSION - A RETROSPECTIVE STUDY AND REVIEW OF THE LITERATURE
L. Pagano et al., FATAL HEMOPTYSIS IN PULMONARY FILAMENTOUS MYCOSIS - AN UNDEREVALUATEDCAUSE OF DEATH IN PATIENTS WITH ACUTE-LEUKEMIA IN HEMATOLOGICAL COMPLETE REMISSION - A RETROSPECTIVE STUDY AND REVIEW OF THE LITERATURE, British Journal of Haematology, 89(3), 1995, pp. 500-505
A retrospective study on a consecutive series of 116 patients affected
by acute leukaemia with documented pulmonary filamentous mycosis (FM)
admitted between 1987 and 1992 to 14 tertiary-care hospitals in Italy
was made in order to evaluate the characteristics of those patients w
ho developed fatal massive haemoptysis. In 59/116 cases of pulmonary F
M the infection was the principal cause of death and in 12 of these pa
tients a massive haemoptysis was responsible for death, The diagnosis
of FM infection was made ante-mortem in only four out of these 12 pati
ents. The autopsy was performed in 11/12 patients and documented a FM
infection, The mycetes isolated were: Hyphomycetes spp, (three patient
s), Mucorales spp, (two patients), Aspergillus spp, (seven patients).
At the time of the massive haemoptysis the mean neutrophil count was 7
.2x10(9)/l, and no patient had relevant thrombocytopenia (mean 184x10(
9)/l, range 28-350) or coagulative abnormalities, The mean time which
elapsed between resolution of chemotherapy-induced neutropenia (WBC <1
0(9)/l) and occurrence of haemoptysis was 7 d. No signs or symptoms pr
edictive of this fatal complication were identified. Massive haemoptys
is can be the cause of death in patients with acute leukaemia and pulm
onary FM which in the majority of patients was not diagnosed in vivo,
This complication occurs most frequently shortly after the recovery fr
om chemotherapy-induced aplasia, The mechanism of lesion is unknown, b
ut it may involve the vascular tropism of FM and the release of leucoc
yte enzymes, Better preventive and therapeutic antifungal treatments a
re needed to avoid this serious, albeit rare, complication.